[ET Net News Agency, 4 June 2024] REMEGEN (09995) rose 10.1% to HK$26.25, breaking
above the 100-D SMA of HK$25.866.
It hits an intra-day high of HK$26.25, and an intra-day low of HK$23.85. The total
shares traded was 1.3 million, with a value of HK$32.83m. The active buy/sell ratio is
67:33, with net buying turnover of HK$10.61m. GOLDMAN SACHS (ASIA) SEC accounts for
greatest net responsive buying turnover of HK$1.34m, with volume weighted average price of
HK$25.252. CHINA INNOVATION MARKET SER accounts for greatest net responsive selling
turnover of HK$3.17m, with volume weighted average price of HK$25.221.
Basic Information
=================
----------------------------------
Nominal 26.250 % Chg +10.06%
High 26.250 Low 23.850
Shares Tr 1.3m Turnover 32.83m
10-D SMA 26.110 %H.V 63.180
20-D SMA 28.650 VWAP 25.215
50-D SMA 28.752 RSI14 44.502
----------------------------------
Status: Breaking above the 100-D SMA, active buy/sell ratio is 67:33, with net buying
turnover of HK$10.61m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
REMEGEN (09995) 26.25 +10.06
GENSCRIPT BIO (01548) 9.20 +11.79
INNOVENT BIO (01801) 36.15 +5.09
KEYMED BIO-B (02162) 33.90 +7.79
WUXI BIO (02269) 11.60 +2.47
BEIGENE (06160) 89.65 +3.05
SKB BIO-B (06990) 181.90 +3.76
ZAI LAB (09688) 15.80 +11.11
AKESO (09926) 43.85 -0.34
ALPHAMAB-B (09966) 2.61 +5.24
---------------------------------------------
(ed)